Viewing Study NCT00055861


Ignite Creation Date: 2025-12-24 @ 12:16 PM
Ignite Modification Date: 2026-01-04 @ 8:55 AM
Study NCT ID: NCT00055861
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Breast Cancer View
None Stage IV Breast Cancer View
Keywords: